Literature DB >> 219044

Decreased cAMP levels in human diploid cells exposed to cholinergic stimuli.

R W Butcher.   

Abstract

Carbachol at a concentration of 1 micron caused very significant decreases in PGE1 stimulated cAMP levels in three human diploid lung fibroblasts, WI-38, MRC-5, and IMR-90. Detailed studies with WI-38 cells showed that carbachol acted at low concentrations and very rapidly, cAMP levels being reduced by 50% in about 1 minute. The effect was moderately reduced but still very significant in Ca++ free medium containing 10(-5)M EGTA. Acetylcholine (in the presence of physostigmine), pilocarpine, and muscarine lowered cAMP levels at concentrations of 1 or 10 micron. The effects of carbachol were exquisitely sensitive to atropine but were unaffected by hexomethonium or d-tubocurarine. These data suggested that the cholinergic response of WI-38 cells was of the muscarinic type.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 219044

Source DB:  PubMed          Journal:  J Cyclic Nucleotide Res        ISSN: 0095-1544


  4 in total

1.  Homologous desensitization of beta-adrenergic receptors in lymphoma cells is not altered by the inactivation of Ni (Gi), the inhibitory guanine nucleotide regulatory protein.

Authors:  R B Clark; T J Goka; M A Proll; J Friedman
Journal:  Biochem J       Date:  1986-04-15       Impact factor: 3.857

Review 2.  Pulmonary fibroblasts, an emerging target for anti-obstructive drugs.

Authors:  Kurt Racké; Susanne Haag; Amit Bahulayan; Mareille Warnken
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-02-13       Impact factor: 3.000

3.  Muscarinic receptors on intact human fibroblasts. Absence of receptor activity in adult skin cells.

Authors:  D A Van Riper; M P Absher; R H Lenox
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

4.  Cyclic AMP accumulation in human fibroblast cultures: diabetics compared with normals.

Authors:  B Israelsson; J Malmquist; T Kjellström
Journal:  Experientia       Date:  1983-12-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.